Davis Jerel is Director & 10% Owner at Repare Therapeutics Inc. (RPTX). They have made 9 open-market trades across 4 companies since 2020, most recently 2025-08-08.
CIK 0001745958
3 open-market purchases totalling $10.8M since 2020, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TSBX | BUY | 2023-07-25 | 2023-07-27 | $12.00 | $2.7M | -5.0% | -8.3% | -79.9% |
| KDNY | SELL | 2023-04-17 | 2023-04-19 | $20.75 | $6.1M | -10.8% | -4.0% | +77.0% |
| KDNY | SELL | 2023-03-01 | 2023-03-03 | $22.75 | $12.7M | -10.1% | -6.3% | +0.6% |
| RPTX | SELL | 2022-12-09 | 2022-12-13 | $16.00 | $4.0M | -5.3% | -14.1% | -33.4% |
| RPTX | SELL | 2022-06-03 | 2022-06-07 | $12.25 | $15.3M | -8.2% | +7.9% | -17.0% |
| KDNY | SELL | 2022-01-03 | 2022-01-05 | $16.00 | $16.0M | -6.7% | -15.8% | +2.9% |
| KDNY | SELL | 2021-08-27 | 2021-08-31 | $14.00 | $11.9M | -4.0% | -6.2% | +14.8% |
| GRPH | BUY | 2021-06-29 | 2021-07-01 | $17.00 | $3.1M | -6.5% | -23.5% | -39.2% |
| RPTX | BUY | 2020-06-23 | 2020-06-25 | $20.00 | $5.0M | -14.8% | -34.0% | -0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.